Effect of PGE2 on interleukin-1 and superoxide release from primary-cultured human hepatic macrophages. 1992

N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

In order to learn more about how human hepatic macrophages function, we analyzed the effect of exogenous PGE2 on the amounts of interleukin-1 (IL-1) and superoxide (O2-) released from primary-cultured human hepatic macrophages (HHM phi). When endogenous PGE2 production was blocked by indomethacin, exogenous PGE2 reduced IL-1 release from HHM phi in a dose-dependent manner, whereas it tended to increase O2- release from HHM phi. These results may suggest the probable contribution of PGE2 in regulating HHM phi mediator release in vivo.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
December 1988, Biochemical and biophysical research communications,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
June 1986, Agents and actions,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
January 1995, Mediators of inflammation,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
September 2005, The Biochemical journal,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
August 1991, Biochemical and biophysical research communications,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
May 1993, Acta endocrinologica,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
November 1994, Agents and actions,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
November 1989, Nihon Kyobu Shikkan Gakkai zasshi,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
April 1997, Biochimica et biophysica acta,
N Funaki, and S Arii, and Y Adachi, and H Higashituji, and S Fujita, and M Furutani, and M Mise, and S Ishiguro, and T Kitao, and J Tanaka
May 1989, The American journal of physiology,
Copied contents to your clipboard!